Focused Categories for Clearer Understanding

Pharmacology

lipid-lowering drugs, LDL drugs pharmacology, Bempedoic Acid, nexletol, statin intolerance, busti

Pharmacology

ezetimibe, cholesterol absorption inhibitor, zetia, ldl cholesterol lowering, antilipemic drugs, cardiology pharmacology, busti

Pharmacology

omega 3 fatty acids, omega-3 fatty acids, fish oil, icosapent ethyl, vascepa, epa, dha, epa vs dha, pufa, polyunsaturated fatty acids, hypertriglyceridemia, triglyceride lowering, severe hypertriglyceridemia, lipid lowering drugs, lipid management, dr busti

Pharmacology

statins, statins pharmacology, HMG CoA reductase inhibitors, LDL lowering, lipid lowering drugs, hyperlipidemia, atorvastatin, rosuvastatin, simvastatin, pravastatin, high intensity statin, ASCVD prevention, cardiovascular risk reduction, statin side effects, statin myopathy, rhabdomyolysis, NCLEX pharmacology, drbusti

Pharmacology

glp 1 receptor agonist, glp1 agonists, semaglutide, ozempic, wegovy, rybelsus, liraglutide, victoza, saxenda, dulaglutide, trulicity, exenatide, byetta, bydureon, diabetes pharmacology, type 2 diabetes medications, incretin mimetics, weight loss medications, glucose lowering drugs, anthony busti, dr busti

Pharmacology

meglitinides, repaglinide, nateglinide, type 2 diabetes, diabetes pharmacology, insulin secretagogues, repaglinide pharmacology, nateglinide pharmacology, busti, dr busti, Anthony Busti

Pharmacology

sglt2 inhibitors, bexagliflozin, canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, jardiance, type2diabetes, diabetes pharmacology, antidiabetic drugs, diabetes medications, sglt2 mechanism, diabetes treatment, pharmacology made easy, busti, dr busti, anthony busti

Pharmacology

sulfonylureas, glipizide, glyburide, glimepiride, type 2 diabetes, t2d pharmacology, diabetes medications, antidiabetic drugs, diabetes pharmacology, pharmacology lecture, step 1 pharmacology, mechanism of action sulfonylureas, second generation sulfonylureas, busti, dr busti, anthony busti

Pharmacology

pioglitazone, tzd, thiazolidinediones, par gamma agonist, insulin sensitizer, type 2 diabetes, diabetes pharmacology, antidiabetic drugs, oral diabetes meds, glucose control, a1c reduction, pioglitazone side effects, heart failurer isk, rosiglitazone, busti, dr busti, anthony busti

Pharmacology

LABA, long acting beta agonist, LABA inhaler, salmeterol, formoterol, vilanterol, olodaterol, indacaterol, asthma pharmacology, COPD pharmacology, bronchodilators, asthma inhalers, COPD inhalers, ICS LABA combination, SMART therapy, bronchospasm treatment, airway smooth muscle, beta2 agonist, respiratory pharmacology, busti, dr busti, anthony busti

Pharmacology

SABA inhaler, albuterol inhaler, short acting beta agonist, SABA bronchodilator, asthma rescue inhaler, COPD rescue inhaler, rescue inhaler pharmacology, albuterol pharmacology, levalbuterol, bronchodilators for asthma, bronchodilators for COPD, beta2 agonist mechanism of action, asthma medications, asthma pharmacology, COPD pharmacology, inhaler technique, MDI inhaler, nebulizer albuterol, albuterol side effects, busti

Pharmacology

LAMA, COPD, long acting muscarinic antagonist, antimuscarinic bronchodilator, tiotropium, Spiriva, umeclidinium, Incruse Ellipta, glycopyrrolate, aclidinium, Tudorza Pressair, COPD pharmacology, respiratory pharmacology, bronchodilators, COPD inhalers, maintenance inhaler, COPD treatment, GOLD guidelines, busti, dr busti